Biopharmaceutical company Biocon on Tuesday announced the appointment of Mukesh Kamath, Head – Business Finance R&D, as the interim chief financial officer and key managerial personnel of the company, with effect from June 11, 2024. The appointment, it said, is till the time a new CFO is appointed by the board.
Earlier this year, Biocon had said that its Chief Financial Officer (CFO) Indranil Sen has resigned with effect from 16 March 2024. “I hereby tender my resignation from the position of Chief Financial Officer and Key Managerial Personnel of the Company to pursue other career opportunities outside Biocon Group. My last date of working with the Company would be March 15, 2024. I would like to thank the management and the board for the opportunity, and I wish the company all the success in its future endeavors,” Indranil Sen had written. He was appointed as the CFO of the company in April 2021 after Anupam Jindal stepped down.
Mukesh Kamath is a seasoned professional with more than 27 years of financial experience. Currently, Mukesh oversees Business Finance R & D, Indirect taxation, Capex, and other finance-related functions. Since joining Biocon in 2004 as a Management Executive, he has worked across all areas of finance within the Biocon Group.
Mukesh Kamath is a qualified Chartered Accountant from the Institute of Chartered Accountants of India and holds a BCom degree from Kuvempu University. Prior to joining Biocon, Mukesh Kamath has worked in various roles with United Breweries Limited, Infodesk Manipal Limited and Techsar Technologies Ltd.